The Institute of Advanced Study in Science and Technology, an independent research institute under India's Department of Science and Technology, has invented a smartphone and sensor-based system to support the management of Parkinson's disease.
HOW IT WORKS
The system involves a fluorescence nanoprobe, a smartphone camera, and a mobile app. It aims to detect the concentration of L-dopa (levodopa...
Turkey-based digital health startup h2o therapeutics announced its new Apple Watch-enabled freezing of gait-cuing feature, dubbed Foggy, designed for Parkinson’s Disease patients has received FDA listing as a Class II medical device and is available via prescription.
According to the Parkinson’s Foundation, freezing of gait is a symptom of Parkinson’s Disease in which a patient experiences a...
New Parkinson's app uses metronome beats to train gait
A new mobile app for people with Parkinson's Disease helps them walk better using metronome beats.
The gait re-training tool, developed as part of a larger clinical trial for PD research, delivers rhythmic metronomic beats that trigger movement.
Now developed separately as an app called Walking Tall, it now features training sessions on...
The Michael J. Fox Foundation (MJFF) has announced a partnership with New York-based H1, a healthcare data company, to streamline its search for physicians actively treating Parkinson's disease patients and gather information on patient populations and treatment approaches.
MJFF will utilize H1's Trial Landscape, an AI-enabled platform that uses performance data to gain insights into clinical...
h2o Therapeutics, a digital health company that develops AI, augmented reality and mobile-based therapeutics, is partnering with global healthcare company AmerisourceBergen to commercialize its Parkinson's disease-focused offering dubbed Parky.
Parky, which received 510(k) clearance last year, is a prescription mobile app that utilizes the Apple Watch to monitor an individual's Parkinson's...
Digital health technology company NeuroRPM has received FDA 510(k) clearance for its AI-enabled remote monitoring app that utilizes an Apple Watch to track common Parkinson's symptoms such as bradykinesia, tremor and dyskinesia.
Bradykinesia is slowness of movement, and dyskinesia is involuntary or erratic movements.
The Washington D.C.-based company's algorithms are embedded in the Apple Watch...
California-based Rune Labs, a precision neurology software and data platform company, is partnering with BlueRock Therapeutics, a clinical-stage biopharmaceutical company and subsidiary of Bayer AG, to aid in studying Parkinson's disease.
BlueRock will utilize Rune Labs' clinical development platform, StriveStudy, for clinical trial enrollment, real-world evidence data generation and monitoring...
A research team led by engineers and neurologists at RMIT University has come up with a mobile app that uses a person's voice to screen for Parkinson's disease and severe COVID-19.
HOW IT WORKS
The app uses AI to analyse the changes in a person's voice in just 10 seconds. The research gathered voice recordings of people with Parkinson's and a control group saying three sounds – A, O, and M,...
Brain data startup Rune Labs announced Tuesday it received FDA 510(k) clearance to use its StrivePD app to monitor Parkinson's disease patients' symptoms through the Apple Watch.
The StrivePD system uses Apple's Movement Disorder API to track tremors and dyskinesia, or uncontrolled, involuntary body movement. Patients can also use the app to log their medications, side effects and other symptoms...
Lunit gets first go-ahead for South Korea IPO
AI startup Lunit has received preliminary approval from the Korea Exchange for its initial public offering on the KOSDAQ.
This comes five months after it raised $61 million in a fundraising event that was held to seek global partners.
In a recent statement, Lunit said it plans to file its registration statement within the first half of 2022 to...
